X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2435) 2435
Book Review (408) 408
Publication (268) 268
Book Chapter (25) 25
Book / eBook (18) 18
Conference Proceeding (7) 7
Newsletter (7) 7
Dissertation (5) 5
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2064) 2064
animals (1392) 1392
ophthalmology (1258) 1258
humans (1190) 1190
angiogenesis (883) 883
male (703) 703
cornea (645) 645
mice (639) 639
neovascularization (583) 583
female (568) 568
corneal neovascularization (537) 537
disease models, animal (441) 441
expression (435) 435
endothelial growth-factor (423) 423
eye diseases (379) 379
corneal neovascularization - pathology (349) 349
rabbits (336) 336
corneal neovascularization - drug therapy (332) 332
bevacizumab (329) 329
sense organs (309) 309
vascular endothelial growth factor (295) 295
inflammation (294) 294
rats (290) 290
cells, cultured (282) 282
cells (269) 269
corneal neovascularization - metabolism (259) 259
middle aged (250) 250
cornea - pathology (247) 247
mice, inbred c57bl (245) 245
adult (233) 233
analysis (224) 224
transplantation (224) 224
cornea - blood supply (218) 218
inhibition (217) 217
vegf (207) 207
angiogenesis inhibitors - therapeutic use (202) 202
cell biology (202) 202
angiogenesis inhibitors - administration & dosage (198) 198
cornea - metabolism (197) 197
wound healing (197) 197
aged (196) 196
in-vitro (195) 195
vascular endothelial growth factor a - antagonists & inhibitors (193) 193
mice, inbred balb c (192) 192
genetic structures (182) 182
biochemistry & molecular biology (180) 180
article (176) 176
macular degeneration (176) 176
research (172) 172
vascular endothelial growth factor a - metabolism (172) 172
lymphangiogenesis (169) 169
immunohistochemistry (166) 166
cornea - drug effects (164) 164
corneal transplantation (159) 159
gene expression (156) 156
research article (155) 155
corneal neovascularization - prevention & control (153) 153
in-vivo (151) 151
treatment outcome (149) 149
medicine (148) 148
medicine, research & experimental (148) 148
eye (147) 147
care and treatment (140) 140
stem cells (140) 140
cancer (134) 134
proteins (132) 132
administration, topical (130) 130
blotting, western (129) 129
health aspects (129) 129
multidisciplinary sciences (129) 129
apoptosis (127) 127
therapy (127) 127
surgery (126) 126
rodents (124) 124
angiogenesis inhibitors - pharmacology (123) 123
rats, sprague-dawley (123) 123
corneal neovascularization - chemically induced (122) 122
pharmacology & pharmacy (121) 121
cell proliferation (117) 117
endothelial-cells (116) 116
growth (114) 114
corneal neovascularization - etiology (113) 113
medicine & public health (113) 113
reverse transcriptase polymerase chain reaction (113) 113
antibodies, monoclonal, humanized (110) 110
enzyme-linked immunosorbent assay (109) 109
model (108) 108
cytokines (106) 106
endothelium (106) 106
growth-factor (105) 105
physiological aspects (105) 105
vascularization (105) 105
avastin (104) 104
epithelium, corneal - metabolism (103) 103
immunology (100) 100
abridged index medicus (99) 99
epithelium (98) 98
rna, messenger - metabolism (95) 95
vascular endothelial growth factor a - genetics (95) 95
cell proliferation - drug effects (94) 94
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2367) 2367
German (37) 37
French (25) 25
Chinese (13) 13
Korean (12) 12
Spanish (8) 8
Portuguese (7) 7
Russian (7) 7
Japanese (3) 3
Arabic (1) 1
Croatian (1) 1
Hebrew (1) 1
Polish (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Cancer Therapeutics, ISSN 1535-7163, 10/2010, Volume 9, Issue 10, pp. 2641 - 2651
Journal Article
American Journal of Pathology, ISSN 0002-9440, 12/2004, Volume 165, Issue 6, pp. 2177 - 2185
Ocular neovascularization often results in vision impairment. Frequently vascular endothelial cell growth factors (VEGFs) are mainly responsible for the... 
PATHOGENESIS | CPG MOTIFS | CELLS | IN-VITRO | INTEGRINS | DNA | ADULT MICE | NEOVASCULARIZATION | PATHOLOGY | SMALL INTERFERING RNAS | DELIVERY | Vascular Endothelial Growth Factor Receptor-1 - antagonists & inhibitors | Oligodeoxyribonucleotides - administration & dosage | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | RNA, Messenger - metabolism | Vascular Endothelial Growth Factor A - genetics | Herpes Simplex - drug therapy | Vascular Endothelial Growth Factor Receptor-2 - genetics | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Keratitis, Herpetic - drug therapy | Female | Corneal Neovascularization - etiology | Vascular Endothelial Growth Factor Receptor-1 - genetics | Keratitis, Herpetic - virology | Signal Transduction | RNA, Messenger - genetics | RNA, Small Interfering - pharmacology | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Keratitis, Herpetic - complications | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Corneal Neovascularization - prevention & control | Herpes Simplex - virology | Animals | Simplexvirus - isolation & purification | Epithelium, Corneal - metabolism | Herpes Simplex - complications | Mice | Mice, Inbred BALB C | Epithelium, Corneal - virology | Index Medicus | Abridged Index Medicus | Original Research Paper
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 05/2011, Volume 31, Issue 5, pp. 1024 - 1032
OBJECTIVE—Inflammation is closely linked to angiogenesis, and Toll-like receptors (TLRs) are the key mediators of inflammatory responses. However, the impact... 
macrophages | HMGB1 | inflammation | angiogenesis | Toll-like receptor | PROGENITOR CELLS | MURINE MACROPHAGES | LIVER ISCHEMIA | FACTOR EXPRESSION | CORNEAL NEOVASCULARIZATION | EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION | PERIPHERAL VASCULAR DISEASE | EXTRACELLULAR HMGB1 | HEMATOLOGY | ENDOTHELIAL GROWTH-FACTOR | GLYCATION END-PRODUCTS | INNATE IMMUNITY | Neovascularization, Physiologic - drug effects | Toll-Like Receptor 2 - genetics | Male | Peptide Fragments - pharmacology | Corneal Neovascularization - genetics | Cornea - blood supply | Cornea - drug effects | Time Factors | Toll-Like Receptor 4 - deficiency | HMGB1 Protein - metabolism | Corneal Neovascularization - physiopathology | Female | Cornea - pathology | Toll-Like Receptor 4 - antagonists & inhibitors | HMGB1 Protein - antagonists & inhibitors | Disease Models, Animal | Signal Transduction | Endothelial Cells - metabolism | Mice, Inbred C57BL | Toll-Like Receptor 4 - genetics | Toll-Like Receptor 2 - metabolism | Corneal Neovascularization - chemically induced | Chemotaxis | Toll-Like Receptor 4 - metabolism | Corneal Neovascularization - prevention & control | Mice, Knockout | Cornea - metabolism | Macrophages - metabolism | Animals | Corneal Neovascularization - metabolism | Lipopolysaccharides - pharmacology | Mice | Angiogenic Proteins - metabolism | Corneal Neovascularization - pathology | Sodium Hydroxide | Index Medicus
Journal Article
Biomaterials, ISSN 0142-9612, 2016, Volume 109, pp. 12 - 22
Abstract Angiogenesis is the process of formation of new blood vessels, which is essential to human biology, and also plays a crucial role in several... 
Advanced Basic Science | Dentistry | Graphene oxide | Serum albumin | Anti-angiogenesis | Vascular endothelial growth factor | Corneal neovascularization | Blood vessel | MATERIALS SCIENCE, BIOMATERIALS | ENGINEERING, BIOMEDICAL | SERUM | TUMOR ANGIOGENESIS | CELL MIGRATION | DELIVERY | NANOPARTICLES | IN-VITRO | CRITICAL REGULATOR | BINDING | ENDOTHELIAL GROWTH-FACTOR | Neovascularization, Physiologic - drug effects | Rabbits | Human Umbilical Vein Endothelial Cells - drug effects | Humans | Oxides - chemistry | Angiogenesis Inhibitors - pharmacology | Vascular Endothelial Growth Factor A - metabolism | Nanostructures | Chick Embryo | Cell Movement - drug effects | Thermodynamics | Animals | Cattle | Human Umbilical Vein Endothelial Cells - cytology | Surface Properties | Chorioallantoic Membrane - drug effects | Protein Binding | Serum Albumin, Bovine - chemistry | Cell Proliferation - drug effects | Eye - drug effects | Graphite - chemistry | Corneal Neovascularization - pathology | Graphite - pharmacology | Chorioallantoic Membrane - blood supply | Endothelial growth factors | Tissue engineering | Immunoglobulin G | Albumin | Metastasis | Endothelium | Macular degeneration | Fibrin | Adsorption | Graphene | Fibrinogen | Physiological aspects | Neovascularization | Anticoagulants (Medicine) | Blood proteins | Index Medicus | Binding | Trapping | Blood vessels | Strategy | Oxides | Formations | Chemical compounds
Journal Article
Journal Article
Cardiovascular Research, ISSN 0008-6363, 01/2015, Volume 105, Issue 1, pp. 107 - 117
Aims The recombinant epidermal growth factor-like domain plus the serine/threonine-rich domain of thrombomodulin (rTMD23) promotes angiogenesis and accelerates... 
Angiogenesis | Activated protein C | Syndecan-4 | Thrombomodulin | Type I fibroblast growth factor receptor | LEWIS Y ANTIGEN | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | LECTIN-LIKE DOMAIN | FIBROBLAST-GROWTH-FACTOR | SIGNAL-TRANSDUCTION | INFLAMMATION | ENDOTHELIAL-CELLS | INHIBITOR | EXPRESSION | EGF RECEPTOR | Human Umbilical Vein Endothelial Cells | Neovascularization, Physiologic - drug effects | Phosphorylation | Humans | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Thrombomodulin - physiology | Receptor, Fibroblast Growth Factor, Type 1 - physiology | Gene Knockdown Techniques | HEK293 Cells | Angiogenesis Inducing Agents - pharmacology | Thrombomodulin - genetics | Corneal Neovascularization - etiology | Ischemia - pathology | Protein Structure, Tertiary | Syndecan-4 - metabolism | Rats | Recombinant Proteins - chemistry | Ischemia - physiopathology | Pyrimidines - pharmacology | Recombinant Proteins - pharmacology | Thrombomodulin - chemistry | Rats, Sprague-Dawley | Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors | Neovascularization, Physiologic - physiology | Animals | Ischemia - drug therapy | Hindlimb - blood supply | Mice | Mice, Inbred BALB C | Protein Kinase Inhibitors - pharmacology | Protein C - metabolism | Angiogenesis Inducing Agents - chemistry | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 04/1999, Volume 398, Issue 6726, pp. 381 - 381
Journal Article
Nature protocols, ISSN 1754-2189, 2007, Volume 2, Issue 10, pp. 2545 - 2550
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 12/2008, Volume 118, Issue 12, pp. 3904 - 3916
Journal Article
ACS Nano, ISSN 1936-0851, 04/2013, Volume 7, Issue 4, pp. 3264 - 3275
Journal Article
Cell Cycle, ISSN 1538-4101, 04/2019, Volume 18, Issue 6-7, pp. 661 - 669
Corneal neovascularization (CRNV) is a prevalence eye disorder that affects the transparency and refraction properties of eyes. To explore the correlation... 
MIAT | cell proliferation | Corneal neovascularization | Ang II | APOPTOSIS | CELL-PROLIFERATION | ANGIOTENSIN-CONVERTING ENZYME | CELL BIOLOGY | NONCODING RNA H19 | INHIBITION | ALKALI BURN | MOUSE MODEL | GROWTH-FACTOR | NEOVASCULARIZATION | EXPRESSION
Journal Article